NCT07797712 Impact of Mirror Therapy Combined With Conventional Training on Gait and Lower Limb Motor Function Among Post-Stroke Patients
| NCT ID | NCT07797712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ibadat International University, Islamabad |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2026-04-15 |
| Primary Completion | 2026-09-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2026-04-15 with a primary completion date of 2026-09-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effects of mirror therapy combined with conventional training on gait and lower limb motor function among post-stroke patients. Stroke remains a worldwide health crisis, persistently ranking as a leading cause of long-term severe disability. The study will evaluate the gait and lower limb motor function.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with the first-ever unilateral stroke. * Duration of stroke between 3 months and 6 months (subacute to chronic stage). * Both male and female patients aged 40 to 70 years. * Ability to walk at least 10 meters independently. * Mini Mental State Examination (MMSE) score \>24. * Brunnstrom stage of recovery for the lower limb is \> 3, indicating some voluntary movement out of synergy. Exclusion Criteria: * Severe cognitive impairment, perceptual deficits, or inability to follow simple verbal commands (e.g., severe aphasia or low MMSE score). * Presence of other neurological disorders affecting motor performance such as Parkinson's disease, multiple sclerosis, traumatic brain injury, or cerebellar disorders. * Severe musculoskeletal disorders of the lower limb, including fracture, contracture, severe osteoarthritis, or pain limiting participation in exercise. * Uncontrolled medical conditions such as unstable hypertension, uncontrolled diabetes mellitus, a recent cardiac event, or other conditions making exercise unsafe. * Severe visual impairment, vestibular dysfunction, or hearing loss that may interfere with treatment instructions or mirror-based feedback. * Severe unilateral neglect (hemispatial neglect) or apraxia interfering with task performance. * Current participation in another physiotherapy, rehabilitation, or interventional research study during the data collection period.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07797712 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07797712 currently recruiting?
Yes, NCT07797712 is actively recruiting participants. Contact the research team at ammarkhanazxc36@gmail.com for enrollment information.
Where is the NCT07797712 trial being conducted?
This trial is being conducted at Quetta, Pakistan.
Who is sponsoring the NCT07797712 clinical trial?
NCT07797712 is sponsored by Ibadat International University, Islamabad. The trial plans to enroll 52 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.